Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Receivables - Other (2016 - 2018)

Historic Receivables - Other for Surgery Partners (SGRY) over the last 5 years, with Q1 2018 value amounting to $20.5 million.

  • Surgery Partners' Receivables - Other rose 78427.65% to $20.5 million in Q1 2018 from the same period last year, while for Mar 2018 it was $20.5 million, marking a year-over-year increase of 78427.65%. This contributed to the annual value of $2.5 million for FY2016, which is 13097.01% up from last year.
  • As of Q1 2018, Surgery Partners' Receivables - Other stood at $20.5 million, which was up 78427.65% from $19.6 million recorded in Q3 2017.
  • Over the past 5 years, Surgery Partners' Receivables - Other peaked at $20.5 million during Q1 2018, and registered a low of $1.1 million during Q4 2014.
  • Moreover, its 5-year median value for Receivables - Other was $1.1 million (2014), whereas its average is $4.9 million.
  • Per our database at Business Quant, Surgery Partners' Receivables - Other changed by 0.0% in 2015 and then surged by 78427.65% in 2018.
  • Surgery Partners' Receivables - Other (Quarter) stood at $1.1 million in 2014, then changed by 0.0% to $1.1 million in 2015, then skyrocketed by 130.97% to $2.5 million in 2016, then surged by 691.6% to $19.6 million in 2017, then grew by 4.44% to $20.5 million in 2018.
  • Its last three reported values are $20.5 million in Q1 2018, $19.6 million for Q3 2017, and $2.3 million during Q2 2017.